Track TCRT and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Alaunos Therapeutics Inc
501 E. Las Olas Blvd., Fort Lauderdale, FL, United States, 33301
IPO
2005
Employees
1
Industry
Biotechnology
Sector
Healthcare
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
Insider Transactions
Quarterly buy vs. sell activity
Sell (left)Buy (right)
Q3 20231-1
0
Analyst Ratings
1 analysts covering
Hold100%recommend hold
Buy
0
Hold
1
Sell
0